<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01973855</url>
  </required_header>
  <id_info>
    <org_study_id>2012ZX10004301-003</org_study_id>
    <nct_id>NCT01973855</nct_id>
  </id_info>
  <brief_title>Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms</brief_title>
  <official_title>Syndrome of Fever Associated With Bleeding of Chinese and Western Medicine Diagnosis and Treatment of Infectious Diseases Plans and Severe Clinical Treatment Research</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangzhou 8th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangzhou 8th People's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To meet eligibility criteria, this study and informed consent of the syndrome of fever
      associated with bleeding of infectious diseases, severe patients to carry out multicenter,
      practical randomized controlled clinical research, to compare the curative effect of western
      medicine, combining Chinese and western medicine treatment, and security, and pathogenesis of
      TCM and syndrome, severe immune related factor and syndrome type of traditional Chinese
      medicine, Chinese medicine prescriptions mechanism research.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized method: using large sample, central randomized, parallel comparison of Chinese and
      western medicine and western medicine group.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>Anytime of the clinical trail from 2011.1.1 to 2015.12.30</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety outcome</measure>
    <time_frame>From 2012.1 to 2015.12</time_frame>
    <description>With adverse events as the calculation basis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Viral Haemorrhagic Fever</condition>
  <condition>Dengue Fever</condition>
  <arm_group>
    <arm_group_label>TCM and Western Medicine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TCM and Western Medicine:First Infectious diseases soup recipe,every time a dose,Two times a day;Ribavirin 10-15mg per kg every time Western Medicine：Ribavirin 10-15mg per kg every time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Western Medicine</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Western Medicine：Ribavirin 10-15mg per kg every time</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Western Medicine</intervention_name>
    <description>Physical cooling,Hydrocortisone</description>
    <arm_group_label>TCM and Western Medicine</arm_group_label>
    <other_name>Ribavirin,</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TCM and Western Medicine</intervention_name>
    <description>Third Infectious diseases soup recipe</description>
    <arm_group_label>TCM and Western Medicine</arm_group_label>
    <arm_group_label>Western Medicine</arm_group_label>
    <other_name>Second Infectious diseases soup recipe and Ribavirin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Viral diseases, such as dengue fever, kidney of hemorrhagic fever, such as xinjiang
             hemorrhagic fever; Or clinical has fever associated with bleeding as the main
             performance, and confirmed as the new emergent infectious diseases

        Exclusion Criteria:

          -  Diagnosed with flu, hand, foot and mouth disease, viral hepatitis (except the
             carrier), liver cirrhosis after hepatitis, AIDS, rabies, encephalitis, polio, measles,
             German measles, chickenpox, herpes, infectious mononucleosis, infectious atypical
             pneumonia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tan X Hua</last_name>
    <role>Study Director</role>
    <affiliation>Guangzhou 8th hospitol</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tan X Hua</last_name>
    <phone>13500039656</phone>
    <email>Gz8htxh@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xi 'an eighth people's hospital</name>
      <address>
        <city>XiAn</city>
        <state>Shanxi</state>
        <zip>710000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xu R Fang</last_name>
      <phone>13008415052</phone>
      <email>xurongfang@vip.sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2013</study_first_submitted>
  <study_first_submitted_qc>October 31, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2013</study_first_posted>
  <last_update_submitted>October 31, 2013</last_update_submitted>
  <last_update_submitted_qc>October 31, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangzhou 8th People's Hospital</investigator_affiliation>
    <investigator_full_name>Xinghua Tan</investigator_full_name>
    <investigator_title>Director of Department of infection area</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fever</mesh_term>
    <mesh_term>Dengue</mesh_term>
    <mesh_term>Hemorrhagic Fevers, Viral</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ribavirin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

